US › Healthcare

Talphera Inc. (TLPH)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$1.36+2.26%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Revenue YoY
-100.0%
Net profit
$-2.6M
Profit YoY
+1.4%
EPS
$-0.05
EPS estimate
$-0.08

EPS came in at -0.05 against a street estimate of -0.08 — a beat of 37.5%.

Key statistics

Market cap
$66.4M
Forward P/E
1.0
P/B
3.61
Book value
$0.34
EPS (TTM)
$-0.28
52-week high
$1.57
52-week low
$0.39
50-day MA
$1.07
200-day MA
$1.02
Beta
0.70

Analyst view

Analysts rate Talphera Inc. a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $3.17.

Shareholding

Insiders
21.41%
Institutions
34.79%

Largest institutional holders

FundStake
AIGH Capital Management, LLC8.98%
Rock Springs Capital Management LP6.92%
Nantahala Capital Management, LLC6.73%
Rosalind Advisors, Inc.6.46%
Bleichroeder LP2.52%
CANTOR FITZGERALD, L. P.1.71%
Empery Asset Management, LP1.14%
Caption Management, LLC1.08%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Talphera Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.